Assembly Biosciences, Inc.

NasdaqGS:ASMB 株式レポート

時価総額：US$95.5m

Assembly Biosciences マネジメント

マネジメント 基準チェック /34

Assembly Biosciencesの CEO はJason Okazakiで、 Aug2022年に任命され、 の在任期間は 2.25年です。 の年間総報酬は$ 1.37Mで、 43.7%給与と56.3%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.21%を直接所有しており、その価値は$ 200.07K 。経営陣と取締役会の平均在任期間はそれぞれ4年と4.8年です。

主要情報

Jason Okazaki

最高経営責任者

US$1.4m

報酬総額

CEO給与比率43.7%
CEO在任期間2.3yrs
CEOの所有権0.2%
経営陣の平均在職期間4yrs
取締役会の平均在任期間4.8yrs

経営陣の近況

Recent updates

Analysts Just Slashed Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Numbers

Nov 13
Analysts Just Slashed Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Numbers

Here's Why Assembly Biosciences (NASDAQ:ASMB) Must Use Its Cash Wisely

Aug 17
Here's Why Assembly Biosciences (NASDAQ:ASMB) Must Use Its Cash Wisely

Will Assembly Biosciences (NASDAQ:ASMB) Spend Its Cash Wisely?

Feb 27
Will Assembly Biosciences (NASDAQ:ASMB) Spend Its Cash Wisely?

We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Nov 09
We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Jason Okazaki to succeed John McHutchison as Assembly Biosciences CEO at year-end

Oct 05

Assembly Biosciences to discontinue development of inhibitor vebicorvir, cut workforce

Jul 20

We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Jun 08
We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Jan 11
We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

We're Keeping An Eye On Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Sep 03
We're Keeping An Eye On Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate

Assembly Biosciences announces resignation of CFO

Jun 02

Time To Worry? Analysts Just Downgraded Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Outlook

Mar 24
Time To Worry? Analysts Just Downgraded Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Outlook

Assembly Biosciences' (NASDAQ:ASMB) Shareholders Are Down 86% On Their Shares

Feb 05
Assembly Biosciences' (NASDAQ:ASMB) Shareholders Are Down 86% On Their Shares

We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash Wisely

Dec 14
We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash Wisely

Assembly Bio inks deal with Door Pharmaceuticals to develop HBV core protein modulators

Nov 16

Assembly Biosciences EPS beats by $0.69, beats on revenue

Nov 05

CEO報酬分析

Assembly Biosciences の収益と比較して、Jason Okazaki の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$41m

Jun 30 2024n/an/a

-US$46m

Mar 31 2024n/an/a

-US$51m

Dec 31 2023US$1mUS$600k

-US$61m

Sep 30 2023n/an/a

-US$73m

Jun 30 2023n/an/a

-US$81m

Mar 31 2023n/an/a

-US$89m

Dec 31 2022US$2mUS$555k

-US$93m

Sep 30 2022n/an/a

-US$131m

Jun 30 2022n/an/a

-US$127m

Mar 31 2022n/an/a

-US$126m

Dec 31 2021US$1mUS$533k

-US$130m

Sep 30 2021n/an/a

-US$109m

Jun 30 2021n/an/a

-US$94m

Mar 31 2021n/an/a

-US$63m

Dec 31 2020US$4mUS$394k

-US$62m

報酬と市場: Jasonの 総報酬 ($USD 1.37M ) は、 US市場 ($USD 652.28K ) の同規模の企業の平均を上回っています。

報酬と収益: Jasonの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Jason Okazaki (48 yo)

2.3yrs

在職期間

US$1,373,710

報酬

Mr. Jason A. Okazaki serves as Chief Executive Officer and Director at Assembly Biosciences, Inc. since January 01, 2023. He served as Chief Operating Officer of Assembly Biosciences, Inc. since August 1,...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Jason Okazaki
CEO, President & Director2.3yrsUS$1.37m0.21%
$ 200.1k
William Delaney
Chief Scientific Officer3.8yrsUS$811.82k0.16%
$ 149.3k
Nicole White
Chief Manufacturing Officer4yrsUS$705.51k0.17%
$ 161.7k
Uri Lopatin
Co-Founder and Clinical & Scientific Advisor10.3yrsUS$1.50mデータなし
Adam Zlotnick
Co-Founderno dataデータなしデータなし
Jeanette Bjorkquist
Executive Director of Accounting & Treasuryno dataデータなし0.026%
$ 24.9k
Shannon Ryan
Senior Vice President of Investor Relationsno dataデータなしデータなし
Jennifer Troia
Chief Human Resources Officer7yrsデータなしデータなし
Anuj Gaggar
Chief Medical Officerless than a yearデータなしデータなし
Thomas Rollins
Executive Officer6.6yrsUS$652.02kデータなし
Amy Figueroa
Investor Relations Consultantno dataデータなしデータなし

4.0yrs

平均在職期間

52yo

平均年齢

経験豊富な経営陣: ASMBの経営陣は 経験豊富 であると考えられます ( 4年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Jason Okazaki
CEO, President & Director1.8yrsUS$1.37m0.21%
$ 200.1k
Adam Zlotnick
Co-Founder10.3yrsデータなしデータなし
Anthony Altig
Independent Director12.8yrsUS$79.58k0.010%
$ 10.0k
William Ringo
Independent Non-Executive Chairman10.3yrsUS$122.08k0.023%
$ 21.9k
John McHutchison
Director5.3yrsUS$64.58k0.25%
$ 234.6k
Susan Mahony
Independent Director6.9yrsUS$74.58k0%
$ 0
Gina Consylman
Independent Director4.1yrsUS$72.08k0%
$ 0
Antonio Bertoletti
Member of Scientific Advisory Board4.8yrsデータなしデータなし
Edward Gane
Member of Scientific Advisory Board4.8yrsデータなしデータなし
Patrick Kennedy
Member of Scientific Advisory Board4.8yrsデータなしデータなし
Alex Thompson
Member of Scientific Advisory Board4.8yrsデータなしデータなし
Stephan Urban
Member of Scientific Advisory Board4.8yrsデータなしデータなし

4.8yrs

平均在職期間

63yo

平均年齢

経験豊富なボード: ASMBの 取締役会 は 経験豊富 であると考えられます ( 4.8年の平均在任期間)。